Risk of complications with use of aspirin during renal biopsy: A systematic review.

CONCLUSIONS: There is low-quality evidence on the effect of aspirin on bleeding risk from PRB. It is reasonable to discontinue aspirin 7 - 10 days prior to nonemergent biopsies, in accordance with guidelines. Given the results from the primary studies, it is reasonable to perform randomized controlled trials to obtain high-quality evidence to inform clinical practice.
.
PMID: 29319492 [PubMed - as supplied by publisher]

Source: Clinical Nephrology - January 10, 2018 Category: Urology & Nephrology Authors: Kumar V, Mitchell MD, Umscheid CA, Berns JS, Hogan JJ Tags: Clin Nephrol Source Type: research